News About: Pharm. Industry
Jeil Pharm and Cheil Jedang to jointly develop anti-diabetic drug
Jeil Pharm says that in parallel with the government's landmark long-term plan to actively promote the bioengineering technology industry on a continual basis, it will initiate a large-scale R&D new drug project to de...
New price proposal of Gleevec on sharp backlash
The Joint Counter Measure Council for Gleevec Pricing and Expansion of Drug Public Benefits (hereinafter called Gleevec Pricing Council: GPC), a civic organization for fighting against Norvatis' Gleevec pricing policy...
Trast ranks highest in brand image
Trast of SK Pharm placed in the first place having the most influential brand image among anti-arthritic drugs, according to a recent survey of Korea Management Association.
SK Pharm says that a patch type of Trast...
Novartis proposes 24,050 won for Glivec's insurance price per tablet
Novartis Korea says that it has recently proposed to the Ministry of Health and Welfare (MOHW) the insurance price of Glivec by 24,050 won per tablet based on the local drug pricing assessment system of new drugs.
...
Stamina health foods market using silkworm and herbs getting heated
Business industry sources say that the domestic stamina health foods market, which will mark a turnover of about 10 billion won this year, has emerged as an arena of tripartite competition among the domestic firms:
...
Stamina health foods market using silkworm and herbs getting heated
Business industry sources say that the domestic stamina health foods market, which will mark a turnover of about 10 billion won this year, has emerged as an arena of tripartite competition among the domestic firms:
...
Diverse management strategies in pharmaceutical industry eyed
Pharmaceutical business sources say that to well comply with more intensified competition after the implementation of the system of separation of separating drug dispensing from medical practice, some pharmaceutical f...
3 J&J affiliated companies tried for North Korea visits in March.
3 Johnson and Johnson affiliates, Janssen Korea, J&J Korea and J&J Medical Korea, planned to take their chief executive's visits to North Korea. The visit program was for implementing the social welfare program under ...
Foreigner's direct investment for finished drug import to be accelerated.
Foreign multinational drug corporations will put aggressive investments for marketing promotion and importation of finished drugs in Korea for the purpose of expanding their market shares.
Mr. Chang Jae-joon, the m...
Impotence drugs on severe competition in the market.
Following Viagra success other many analogues seem to overflow into the impotence drug markets such as Uprima by Abbott recently, Cialis by E. Lilly and Valdenapil by Bayer very soon.
Further to the above foreign m...
